Triple
T4850535
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | MedImmune |
E108402
|
entity |
| Predicate | SynagisIndication |
P59928
|
FINISHED |
| Object | prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients | Statement: [MedImmune, SynagisIndication, prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: SynagisIndication Context triple: [MedImmune, SynagisIndication, prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients]
-
A.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
B.
serogroup
Indicates that entities are grouped or classified together based on sharing the same serological (antigenic) characteristics.
-
C.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
-
D.
requiresPremedication
Indicates that one entity must receive premedication (a preparatory medical treatment) before another specified procedure, treatment, or action can occur.
-
E.
notableSerogroupsCause
Indicates that certain particularly significant serogroups are responsible for causing a specified disease, condition, or outcome.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd440a89548190a5f14ba6da6b97dc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd6ddd17d881909f7731ff2b460e83 |
completed | March 20, 2026, 3:55 p.m. |
| PD | Predicate disambiguation | batch_69bd6c2557388190a2d15571bacd24f3 |
completed | March 20, 2026, 3:47 p.m. |
| PDg | Predicate description generation | batch_69bd6dda5e808190a26ec85e4499d8e4 |
completed | March 20, 2026, 3:55 p.m. |
Created at: March 20, 2026, 1:25 p.m.